PAMU
HZNP

Pictet Asset Management (UK)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Pictet Asset Management (UK)’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$213M Buy
2,279,478
+254,092
+13% +$23.4M 0.23% 125
2021
Q1 		$186M Buy
2,025,386
+294,630
+17% +$24.9M 0.22% 132
2020
Q4 		$127M Sell
1,730,756
-215,594
-11% -$16M 0.17% 168
2020
Q3 		$151M Buy
1,946,350
+448,921
+30% +$30.9M 0.24% 126
2020
Q2 		$83.2M Buy
+1,497,429
New +$64.1M 0.14% 187

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Pictet Asset Management (UK)'s HZNP Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 13% in Q2 2021, buying an estimated $23.4M and bringing the position to 2,279,478 shares worth $213M. The position accounts for 0.23% of the portfolio, ranked #125.

Pictet Asset Management (UK) first reported a position in HZNP in Q2 2020 and has held it in 5 quarters since. 526 funds tracked by Wall St. Rank hold HZNP as of Q2 2021.

  • Pictet Asset Management (UK) held 2,279,478 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $213M as of Q2 2021.
  • Pictet Asset Management (UK) bought 254,092 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2021, an estimated $23.4M.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.23% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #125 holding.
  • Pictet Asset Management (UK) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and has held it in 5 quarters since.
  • 526 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.